Extension of BS-VI deadline unlikely to do 'any good' to auto industry; buying sentiment likely to remain low after lockdown: Report

During the April-February period of 2019-20, sales witnessed a decline of 12.7% year-on-year on account of weak demand for commercial vehicles, two- and three-wheelers as well as passenger vehicles.

Press Trust of India March 30, 2020 17:46:36 IST
Extension of BS-VI deadline unlikely to do 'any good' to auto industry; buying sentiment likely to remain low after lockdown: Report

Mumbai: The 10-day extension of BS-VI deadline granted by the Supreme Court due to the lockdown is unlikely to do "any good" to the automobile industry amid the coronavirus outbreak, a report said on Monday.

The existing emission norms or Bharat Stage (BS)-IV were to be replaced by new BS-VI regulations from 1 April.

However, the apex court on 27 March relaxed the 31 March deadline and allowed the sale of the unsold stock of BS-IV vehicles for 10 days after the expiry of the lockdown period, except in Delhi and the NCR.

Extension of BSVI deadline unlikely to do any good to auto industry buying sentiment likely to remain low after lockdown Report

Representational image. Reuters

The deadline was stretched on the plea of the Federation of Automobile Dealers Association (FADA), which had sought a additional time of two months to clear the BS-IV inventory.

The nationwide lockdown imposed on 4 March will last till 14 April.

"While the industry players were looking for a three-month extension (till 30 June), the 10-day extension post the lockdown by the Supreme Court is not expected to do any good to the industry given the current situation due to COVID-19 (the disease caused by coronavirus )," ratings agency CARE Ratings said in a report.

According to CARE Ratings, the buying sentiment after the lockdown period is likely to be "low" and consumers will be cautious in spending, particularly on luxury and big-ticket items, thereby not meeting the desired objective of clearing the BS-IV inventory with the dealers.

During the April-February period of 2019-20, sales witnessed a decline of about 12.7 percent year-on-year (y-o-y) on account of weak demand for commercial vehicles, two- and three-wheelers as well as passenger vehicles, it said.

Currently, the two-wheeler industry is left with BS-IV inventory worth Rs 4,600 crore, while dealers are left with an approximate inventory of 8.35 lakh units, according to CARE Ratings.

Additionally, with the auto production temporarily suspended due to the lockdown, the Society of Indian Automobile Manufacturers (SIAM) has already estimated a minimum loss of around Rs 2,300 crore per day, it said.

Continued impact of increased cost of ownership in passenger vehicles and two-wheeler segments due to new safety norms and higher insurance costs, increased axle norms and high base of the previous year in the case of commercial vehicles led to the overall decline of automobiles during the April-February period of 2019-20, according to the report.

Also, going forward, with the implementation of BS-VI norms from April, the cost of ownership is further expected to increase by about 12-15 percent, it added.

Overall demand for exports increased by about 5.4 percent y-o-y during 2019-20 (April-February) as against a double-digit growth of over 15.5 percent during the corresponding period of the previous year, on the back of slowdown in the global economies as well as the coronavirus outbreak.

Updated Date:

also read

'Come together to defeat BJP': Mamata Banerjee discusses Oppn unity, Pegasus row with Sonia and Rahul
Politics

'Come together to defeat BJP': Mamata Banerjee discusses Oppn unity, Pegasus row with Sonia and Rahul

Banerjee's visit during the ongoing Parliament's Monsoon Session assumes increased significance with the Opposition cornering the Centre on price rise, increasing cost of fuel and COVID-19 pandemic

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre
India

Over 3.09 crore unutilised vaccine doses available with states and private hospitals, says Centre

It said that more than 45.37 crore vaccine doses have been provided to states and UTs so far through all sources and a further 59,39,010 doses are in the pipeline

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS
India

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS

Replying to a short discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days